In utero and postnatal exposure to antiretrovirals among hiv-exposed but uninfected children in the united states

AIDS Patient Care and STDs

Volumn 25, Issue 7, 2011, Pages 385-394

  Griner, Raymond ^a   Williams, Paige L ^a   Read, Jennifer S ^b   Seage, George R ^c   Crain, Marilyn ^d   Yogev, Ram ^e   Hazra, Rohan ^b   Rich, Kenneth ^f  

^a CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e CHILDREN'S MEMORIAL HOSPITAL   (United States)

^f UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; ATAZANAVIR; EFAVIRENZ; EMTRICITABINE; ETRAVIRINE; FOSAMPRENAVIR; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; TENOFOVIR; VIRUS RNA; ZIDOVUDINE;

ARTICLE; CHILD; COHORT ANALYSIS; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; PREGNANCY; PROSPECTIVE STUDY; UNITED STATES; VIRUS LOAD;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; PUERTO RICO; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; UNITED STATES; VIRAL LOAD;

EID: 79959830059     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2011.0068     Document Type: Article

References (18)

1. Whitmore S, Zhang X, Taylor A. Estimated number of births to HIV-positive women in the United States, 2006 [Abstract 924]. 16th Conference on Retroviruses and Opportunistic Infections. Montreal: February 8-11, 2009.
2. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1- Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. May 24, 2010; pp 1-117. http://aidsinfo.nih.gov/ContentFiles/ PerinatalGL.pdf (Last accessed April 13, 2011).
3. Baroncelli S, Tamburrini E, Ravizza M, et al. Antiretroviral treatment in pregnancy: A six-year perspective on recent trends in prescription patterns, viral load suppression, and pregnancy outcomes. AIDS Patient Care STDs 2009;23:513-520.
4. von Linstow ML, Rosenfeldt V, Lebech AM, et al. Prevention of mother-to-child transmission of HIV in Denmark, 1994- .2008. HIV Med 2010;11:448-456.
5. Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA. Trends in management and outcome of pregnancies in HIVinfected women in the UK and Ireland, 1990-2006. BJOG 2008;115:1078-1086. (Pubitemid 352000353)
6. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002;29: 484-494. (Pubitemid 34456340)
7. Brogly SB, Ylitalo N, Mofenson LM, et al. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children. AIDS 2007;21:929-938. (Pubitemid 46684324)
8. Patel K, Shapiro DE, Brogly SB, et al. Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. J Infect Dis 2010;201:1035-1044.
9. Brogly SB, Abzug MJ, Watts DH, et al. Birth defects among children born to human immunodeficiency virus-infected women: Pediatric AIDS clinical trials protocols 219 and 219C. Pediatr Infect Dis J 2010;29:721-727.
10. Tassiopoulos K, Read JS, Brogly S, et al. Substance use in HIV-Infected women during pregnancy: Self-report versus meconium analysis. AIDS Behav 2010;14:1269-1278.
11. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. October 12, 2006; p 43. http://aidsinfo.nih.gov/ContentFiles/ PerinatalGL000616.pdf (Last accessed April 13, 2011).
12. VIRACEPT- (nelfinavir mesylate) 250mg, 625mg tablets, and powder for oral suspension. [Healthcare Professional Letter] New York, NY: Pfizer Inc.; September 10, 2007. www. fda.gov/downloads/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/UCM154880.pdf (Last accessed April 13, 2011).
13. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1- infected adults and adolescents. Department of Health and Human Services. December 1, 2009; pp. 1-161. www.aidsinfo. nih.gov/ContentFiles/AdultandAdolescentGL001419.pdf (Last accessed April 13, 2011).
14. Foster C, Lyall H, Olmscheid B, Pearce G, Zhang S, Gibb DM. Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: Is it time to move on from zidovudine? HIV Med 2009;10: 397-406.
15. Tarantal AF, Marthas ML, Shaw JP, Cundy K, Bischofberger N. Administration of 9-[2-(R)-(phosphonomethoxy)propyl] adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): Safety and efficacy studies. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20: 323-333. (Pubitemid 29143025)
16. Tarantal AF, Castillo A, Ekert JE, Bischofberger N, Martin RB. Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta). J Acquir Immune Defic Syndr 2002;29:207-220. (Pubitemid 34208529)
17. Gafni RI, Hazra R, Reynolds JC, et al. Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: Impact on bone mineral density in HIV-infected children. Pediatrics. 2006;118:e711-718. (Pubitemid 46089998)
18. England K, Thorne C, European Collaborative Study. Use of neonatal antiretroviral prophylaxis for prevention of mother- to-child transmission of HIV is decreasing in Western Europe. Clin Infect Dis 2009;48:1797-1800.